doxazosin has been researched along with Ovarian Neoplasms in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxazosin is an α1 adrenergic receptor blocker that also exerts antitumor effects." | 1.40 | The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression. ( Dong, SM; Kim, BR; Kim, DY; Lee, SH; Park, MS; Rho, SB, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, MS | 1 |
| Kim, BR | 1 |
| Dong, SM | 1 |
| Lee, SH | 1 |
| Kim, DY | 1 |
| Rho, SB | 1 |
1 other study available for doxazosin and Ovarian Neoplasms
| Article | Year |
|---|---|
The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antihypertensive Agents; Blotting, Western; Cell L | 2014 |